Cellosaurus logo
expasy logo

Cellosaurus 10A-KRAS(G12V) clone 1 (CVCL_F6KT)

[Text][XML][JSON]
Cell line name 10A-KRAS(G12V) clone 1
Synonyms 10A-KRAS (G12V) clone 1
Accession CVCL_F6KT
Resource Identification Initiative To cite this cell line use: 10A-KRAS(G12V) clone 1 (RRID:CVCL_F6KT)
Comments Characteristics: Not tumorigenic in nude-Foxn1nu mice (PubMed=26497685).
Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Gly12Val).
Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
Sequence variations
  • Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
  • Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_0598 (MCF-10A)
Children:
CVCL_F6KX (10A-KRAS(G12V)-Luc)
Sex of cell Female
Age at sampling 36Y
Category Spontaneously immortalized cell line
Publications

PubMed=26497685; DOI=10.18632/oncotarget.6159; PMCID=PMC4742101
Keyata N. Thompson, Rebecca A. Whipple, Jennifer R. Yoon, Michael Lipsky, Monica S. Charpentier, Amanda E. Boggs, Kristi R. Chakrabarti, Lekhana Bhandary, Lindsay K. Hessler, Stuart S. Martin, Michele I. Vitolo;
The combinatorial activation of the PI3K and Ras/MAPK pathways is sufficient for aggressive tumor formation, while individual pathway activation supports cell persistence.
Oncotarget 6:35231-35246(2015)

Entry history
Entry creation22-Oct-2026
Last entry update22-Oct-2026
Version number1